BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Report Library

All Reports
Datamonitor Healthcare I&I: Hereditary Angioedema (HAE) Market Spotlight

November 18, 2019

Hereditary angioedema (HAE) is a rare genetic disorder that causes repeated episodes of swelling that most commonly occur in the intestinal tract, limbs, face, and airway. In about 25% of HAE cases, a non-itching, red rash can develop before or during an attack. The majority of these attacks are self-limiting, but abdominal swelling may lead to nausea, vomiting, and severe pain. Furthermore, throat or laryngeal swelling can cause death due to asphyxiation. Although HAE is generally inherited, 20–25% of cases may occur due to spontaneous mutations, with no indication of HAE in the individual’s family history. HAE affects between 1 in 10,000 and 1 in 50,000 people, and the duration and frequency of attacks vary greatly. Symptoms usually start in adolescence or childhood and continue throughout a person’s lifetime.

This Datamonitor Healthcare report contains a Market Spotlight module.
Indications Covered: Hereditary Angioedema (HAE)
Back to the top Back to the top